Preethi Sundaram - Dec 28, 2021 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Product Devel. Officer
Signature
/s/ Preethi Sundaram
Stock symbol
CPRX
Transactions as of
Dec 28, 2021
Transactions value $
$0
Form type
4
Date filed
12/30/2021, 03:50 PM
Previous filing
Jul 13, 2021
Next filing
Feb 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 +67.5K +22.5% $0.00 368K Dec 28, 2021 Common Stock 67.5K $7.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest in equal tranches, 1/3rd on December 28, 2022, 1/3rd on December 28, 2023 and 1/3rd on December 28, 2024.